Table 2.
Results of the evaluated clinical trials.
| Clinical Trials | % | Average Score | Complexity | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Low | % | Medium | % | High | % | ||||
| Total | 60 | 100.00 | 22.88 | 18 | 30.00 | 23 | 38.33 | 19 | 31.67 |
| Centre 1 | 40 | 66.67 | 22.50 | 14 | 35.00 | 13 | 32.50 | 13 | 32.50 |
| Centre 2 | 20 | 33.33 | 23.63 | 4 | 20.00 | 10 | 50.00 | 6 | 30.00 |
| Haematology | 21 | 35.00 | 23.98 | 6 | 28.57 | 5 | 23.81 | 10 | 47.62 |
| Oncology | 39 | 65.00 | 22.28 | 12 | 30.77 | 18 | 46.15 | 9 | 23.08 |
| Phase I | 6 | 10.00 | 24.92 | 0 | 0.00 | 3 | 50.00 | 3 | 50.00 |
| Phase II | 18 | 30.00 | 21.78 | 10 | 55.56 | 2 | 11.11 | 6 | 33.33 |
| Phase III | 36 | 60.00 | 23.08 | 8 | 22.22 | 18 | 50.00 | 10 | 27.78 |